CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five forces analysis
3.4.Top player positioning
3.5.Market dynamics
3.5.1.Drivers
3.5.2.Restraints
3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market
CHAPTER 4: PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT
4.1 Overview
4.1.1 Market size and forecast
4.2 Portable PFT Devices
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.2.4 Portable PFT Devices Pulmonary Function Testing Devices Market by Type
4.2.4.1 Hardware Market size and forecast, by region
4.2.4.2 Software Market size and forecast, by region
4.3 Complete PFT Devices
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
4.3.4 Complete PFT Devices Pulmonary Function Testing Devices Market by Type
4.3.4.1 Hardware Market size and forecast, by region
4.3.4.2 Software Market size and forecast, by region
CHAPTER 5: PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE
5.1 Overview
5.1.1 Market size and forecast
5.2 Spirometry
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.3 Peak flow meter
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
5.4 Lung Volume Test
5.4.1 Key market trends, growth factors and opportunities
5.4.2 Market size and forecast, by region
5.4.3 Market analysis by country
5.5 Gas Exchange Testing
5.5.1 Key market trends, growth factors and opportunities
5.5.2 Market size and forecast, by region
5.5.3 Market analysis by country
5.6 Maximal Voluntary Ventilation
5.6.1 Key market trends, growth factors and opportunities
5.6.2 Market size and forecast, by region
5.6.3 Market analysis by country
5.7 Others
5.7.1 Key market trends, growth factors and opportunities
5.7.2 Market size and forecast, by region
5.7.3 Market analysis by country
CHAPTER 6: PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION
6.1 Overview
6.1.1 Market size and forecast
6.2 Chronic Obstructive Pulmonary Disease
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market analysis by country
6.3 Asthma
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market analysis by country
6.4 Chronic Shortness of Breath
6.4.1 Key market trends, growth factors and opportunities
6.4.2 Market size and forecast, by region
6.4.3 Market analysis by country
6.5 Restrictive Lung Disease
6.5.1 Key market trends, growth factors and opportunities
6.5.2 Market size and forecast, by region
6.5.3 Market analysis by country
6.6 Others
6.6.1 Key market trends, growth factors and opportunities
6.6.2 Market size and forecast, by region
6.6.3 Market analysis by country
CHAPTER 7: PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER
7.1 Overview
7.1.1 Market size and forecast
7.2 Hospital
7.2.1 Key market trends, growth factors and opportunities
7.2.2 Market size and forecast, by region
7.2.3 Market analysis by country
7.3 Clinical laboratories
7.3.1 Key market trends, growth factors and opportunities
7.3.2 Market size and forecast, by region
7.3.3 Market analysis by country
7.4 Diagnostic Laboratories
7.4.1 Key market trends, growth factors and opportunities
7.4.2 Market size and forecast, by region
7.4.3 Market analysis by country
7.5 Others
7.5.1 Key market trends, growth factors and opportunities
7.5.2 Market size and forecast, by region
7.5.3 Market analysis by country
CHAPTER 8: PULMONARY FUNCTION TESTING DEVICES MARKET, BY REGION
8.1 Overview
8.1.1 Market size and forecast
8.2 North America
8.2.1 Key trends and opportunities
8.2.2 North America Market size and forecast, by Product
8.2.2.1 North America Portable PFT Devices Pulmonary Function Testing Devices Market by Type
8.2.2.2 North America Complete PFT Devices Pulmonary Function Testing Devices Market by Type
8.2.3 North America Market size and forecast, by Test Type
8.2.4 North America Market size and forecast, by Application
8.2.5 North America Market size and forecast, by End user
8.2.6 North America Market size and forecast, by country
8.2.6.1 U.S.
8.2.6.1.1 Market size and forecast, by Product
8.2.6.1.2 Market size and forecast, by Test Type
8.2.6.1.3 Market size and forecast, by Application
8.2.6.1.4 Market size and forecast, by End user
8.2.6.2 Canada
8.2.6.2.1 Market size and forecast, by Product
8.2.6.2.2 Market size and forecast, by Test Type
8.2.6.2.3 Market size and forecast, by Application
8.2.6.2.4 Market size and forecast, by End user
8.2.6.3 Mexico
8.2.6.3.1 Market size and forecast, by Product
8.2.6.3.2 Market size and forecast, by Test Type
8.2.6.3.3 Market size and forecast, by Application
8.2.6.3.4 Market size and forecast, by End user
8.3 Europe
8.3.1 Key trends and opportunities
8.3.2 Europe Market size and forecast, by Product
8.3.2.1 Europe Portable PFT Devices Pulmonary Function Testing Devices Market by Type
8.3.2.2 Europe Complete PFT Devices Pulmonary Function Testing Devices Market by Type
8.3.3 Europe Market size and forecast, by Test Type
8.3.4 Europe Market size and forecast, by Application
8.3.5 Europe Market size and forecast, by End user
8.3.6 Europe Market size and forecast, by country
8.3.6.1 France
8.3.6.1.1 Market size and forecast, by Product
8.3.6.1.2 Market size and forecast, by Test Type
8.3.6.1.3 Market size and forecast, by Application
8.3.6.1.4 Market size and forecast, by End user
8.3.6.2 Germany
8.3.6.2.1 Market size and forecast, by Product
8.3.6.2.2 Market size and forecast, by Test Type
8.3.6.2.3 Market size and forecast, by Application
8.3.6.2.4 Market size and forecast, by End user
8.3.6.3 Italy
8.3.6.3.1 Market size and forecast, by Product
8.3.6.3.2 Market size and forecast, by Test Type
8.3.6.3.3 Market size and forecast, by Application
8.3.6.3.4 Market size and forecast, by End user
8.3.6.4 UK
8.3.6.4.1 Market size and forecast, by Product
8.3.6.4.2 Market size and forecast, by Test Type
8.3.6.4.3 Market size and forecast, by Application
8.3.6.4.4 Market size and forecast, by End user
8.3.6.5 Spain
8.3.6.5.1 Market size and forecast, by Product
8.3.6.5.2 Market size and forecast, by Test Type
8.3.6.5.3 Market size and forecast, by Application
8.3.6.5.4 Market size and forecast, by End user
8.3.6.6 Rest of Europe
8.3.6.6.1 Market size and forecast, by Product
8.3.6.6.2 Market size and forecast, by Test Type
8.3.6.6.3 Market size and forecast, by Application
8.3.6.6.4 Market size and forecast, by End user
8.4 Asia-Pacific
8.4.1 Key trends and opportunities
8.4.2 Asia-Pacific Market size and forecast, by Product
8.4.2.1 Asia-Pacific Portable PFT Devices Pulmonary Function Testing Devices Market by Type
8.4.2.2 Asia-Pacific Complete PFT Devices Pulmonary Function Testing Devices Market by Type
8.4.3 Asia-Pacific Market size and forecast, by Test Type
8.4.4 Asia-Pacific Market size and forecast, by Application
8.4.5 Asia-Pacific Market size and forecast, by End user
8.4.6 Asia-Pacific Market size and forecast, by country
8.4.6.1 Japan
8.4.6.1.1 Market size and forecast, by Product
8.4.6.1.2 Market size and forecast, by Test Type
8.4.6.1.3 Market size and forecast, by Application
8.4.6.1.4 Market size and forecast, by End user
8.4.6.2 China
8.4.6.2.1 Market size and forecast, by Product
8.4.6.2.2 Market size and forecast, by Test Type
8.4.6.2.3 Market size and forecast, by Application
8.4.6.2.4 Market size and forecast, by End user
8.4.6.3 India
8.4.6.3.1 Market size and forecast, by Product
8.4.6.3.2 Market size and forecast, by Test Type
8.4.6.3.3 Market size and forecast, by Application
8.4.6.3.4 Market size and forecast, by End user
8.4.6.4 Australia
8.4.6.4.1 Market size and forecast, by Product
8.4.6.4.2 Market size and forecast, by Test Type
8.4.6.4.3 Market size and forecast, by Application
8.4.6.4.4 Market size and forecast, by End user
8.4.6.5 South Korea
8.4.6.5.1 Market size and forecast, by Product
8.4.6.5.2 Market size and forecast, by Test Type
8.4.6.5.3 Market size and forecast, by Application
8.4.6.5.4 Market size and forecast, by End user
8.4.6.6 Rest of Asia-Pacific
8.4.6.6.1 Market size and forecast, by Product
8.4.6.6.2 Market size and forecast, by Test Type
8.4.6.6.3 Market size and forecast, by Application
8.4.6.6.4 Market size and forecast, by End user
8.5 LAMEA
8.5.1 Key trends and opportunities
8.5.2 LAMEA Market size and forecast, by Product
8.5.2.1 LAMEA Portable PFT Devices Pulmonary Function Testing Devices Market by Type
8.5.2.2 LAMEA Complete PFT Devices Pulmonary Function Testing Devices Market by Type
8.5.3 LAMEA Market size and forecast, by Test Type
8.5.4 LAMEA Market size and forecast, by Application
8.5.5 LAMEA Market size and forecast, by End user
8.5.6 LAMEA Market size and forecast, by country
8.5.6.1 Brazil
8.5.6.1.1 Market size and forecast, by Product
8.5.6.1.2 Market size and forecast, by Test Type
8.5.6.1.3 Market size and forecast, by Application
8.5.6.1.4 Market size and forecast, by End user
8.5.6.2 Saudi Arabia
8.5.6.2.1 Market size and forecast, by Product
8.5.6.2.2 Market size and forecast, by Test Type
8.5.6.2.3 Market size and forecast, by Application
8.5.6.2.4 Market size and forecast, by End user
8.5.6.3 South Africa
8.5.6.3.1 Market size and forecast, by Product
8.5.6.3.2 Market size and forecast, by Test Type
8.5.6.3.3 Market size and forecast, by Application
8.5.6.3.4 Market size and forecast, by End user
8.5.6.4 Rest of LAMEA
8.5.6.4.1 Market size and forecast, by Product
8.5.6.4.2 Market size and forecast, by Test Type
8.5.6.4.3 Market size and forecast, by Application
8.5.6.4.4 Market size and forecast, by End user
CHAPTER 9: COMPANY LANDSCAPE
9.1. Introduction
9.2. Top winning strategies
9.3. Product Mapping of Top 10 Player
9.4. Competitive Dashboard
9.5. Competitive Heatmap
9.6. Key developments
CHAPTER 10: COMPANY PROFILES
10.1 SCHILLER
10.1.1 Company overview
10.1.2 Company snapshot
10.1.3 Operating business segments
10.1.4 Product portfolio
10.1.5 Business performance
10.1.6 Key strategic moves and developments
10.2 COSMED srl
10.2.1 Company overview
10.2.2 Company snapshot
10.2.3 Operating business segments
10.2.4 Product portfolio
10.2.5 Business performance
10.2.6 Key strategic moves and developments
10.3 NSPIRE HEALTH INC
10.3.1 Company overview
10.3.2 Company snapshot
10.3.3 Operating business segments
10.3.4 Product portfolio
10.3.5 Business performance
10.3.6 Key strategic moves and developments
10.4 MGC Diagnostics Corporation
10.4.1 Company overview
10.4.2 Company snapshot
10.4.3 Operating business segments
10.4.4 Product portfolio
10.4.5 Business performance
10.4.6 Key strategic moves and developments
10.5 ndd Medizintechnik AG
10.5.1 Company overview
10.5.2 Company snapshot
10.5.3 Operating business segments
10.5.4 Product portfolio
10.5.5 Business performance
10.5.6 Key strategic moves and developments
10.6 Morgan Scientific Inc.,
10.6.1 Company overview
10.6.2 Company snapshot
10.6.3 Operating business segments
10.6.4 Product portfolio
10.6.5 Business performance
10.6.6 Key strategic moves and developments
10.7 Ganshorn Medizin Electronic
10.7.1 Company overview
10.7.2 Company snapshot
10.7.3 Operating business segments
10.7.4 Product portfolio
10.7.5 Business performance
10.7.6 Key strategic moves and developments
10.8 Minato Holdings Inc
10.8.1 Company overview
10.8.2 Company snapshot
10.8.3 Operating business segments
10.8.4 Product portfolio
10.8.5 Business performance
10.8.6 Key strategic moves and developments
10.9 CHEST M.I., Inc
10.9.1 Company overview
10.9.2 Company snapshot
10.9.3 Operating business segments
10.9.4 Product portfolio
10.9.5 Business performance
10.9.6 Key strategic moves and developments
10.10 Medical Equipment Europe
10.10.1 Company overview
10.10.2 Company snapshot
10.10.3 Operating business segments
10.10.4 Product portfolio
10.10.5 Business performance
10.10.6 Key strategic moves and developments
TABLE 1. GLOBAL PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 2. PULMONARY FUNCTION TESTING DEVICES MARKET, FOR PORTABLE PFT DEVICES, BY REGION, 2021-2031 ($MILLION)
TABLE 3. PULMONARY FUNCTION TESTING DEVICES MARKET FOR PORTABLE PFT DEVICES, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 4. GLOBAL PORTABLE PFT DEVICES PULMONARY FUNCTION TESTING DEVICES MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 5. PULMONARY FUNCTION TESTING DEVICES MARKET, FOR HARDWARE, BY REGION, 2021-2031 ($MILLION)
TABLE 6. PULMONARY FUNCTION TESTING DEVICES MARKET, FOR SOFTWARE, BY REGION, 2021-2031 ($MILLION)
TABLE 7. PULMONARY FUNCTION TESTING DEVICES MARKET, FOR COMPLETE PFT DEVICES, BY REGION, 2021-2031 ($MILLION)
TABLE 8. PULMONARY FUNCTION TESTING DEVICES MARKET FOR COMPLETE PFT DEVICES, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 9. GLOBAL COMPLETE PFT DEVICES PULMONARY FUNCTION TESTING DEVICES MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 10. PULMONARY FUNCTION TESTING DEVICES MARKET, FOR HARDWARE, BY REGION, 2021-2031 ($MILLION)
TABLE 11. PULMONARY FUNCTION TESTING DEVICES MARKET, FOR SOFTWARE, BY REGION, 2021-2031 ($MILLION)
TABLE 12. GLOBAL PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 13. PULMONARY FUNCTION TESTING DEVICES MARKET, FOR SPIROMETRY, BY REGION, 2021-2031 ($MILLION)
TABLE 14. PULMONARY FUNCTION TESTING DEVICES MARKET FOR SPIROMETRY, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 15. PULMONARY FUNCTION TESTING DEVICES MARKET, FOR PEAK FLOW METER, BY REGION, 2021-2031 ($MILLION)
TABLE 16. PULMONARY FUNCTION TESTING DEVICES MARKET FOR PEAK FLOW METER, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 17. PULMONARY FUNCTION TESTING DEVICES MARKET, FOR LUNG VOLUME TEST, BY REGION, 2021-2031 ($MILLION)
TABLE 18. PULMONARY FUNCTION TESTING DEVICES MARKET FOR LUNG VOLUME TEST, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 19. PULMONARY FUNCTION TESTING DEVICES MARKET, FOR GAS EXCHANGE TESTING, BY REGION, 2021-2031 ($MILLION)
TABLE 20. PULMONARY FUNCTION TESTING DEVICES MARKET FOR GAS EXCHANGE TESTING, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 21. PULMONARY FUNCTION TESTING DEVICES MARKET, FOR MAXIMAL VOLUNTARY VENTILATION, BY REGION, 2021-2031 ($MILLION)
TABLE 22. PULMONARY FUNCTION TESTING DEVICES MARKET FOR MAXIMAL VOLUNTARY VENTILATION, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 23. PULMONARY FUNCTION TESTING DEVICES MARKET, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
TABLE 24. PULMONARY FUNCTION TESTING DEVICES MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 25. GLOBAL PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 26. PULMONARY FUNCTION TESTING DEVICES MARKET, FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE, BY REGION, 2021-2031 ($MILLION)
TABLE 27. PULMONARY FUNCTION TESTING DEVICES MARKET FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 28. PULMONARY FUNCTION TESTING DEVICES MARKET, FOR ASTHMA, BY REGION, 2021-2031 ($MILLION)
TABLE 29. PULMONARY FUNCTION TESTING DEVICES MARKET FOR ASTHMA, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 30. PULMONARY FUNCTION TESTING DEVICES MARKET, FOR CHRONIC SHORTNESS OF BREATH, BY REGION, 2021-2031 ($MILLION)
TABLE 31. PULMONARY FUNCTION TESTING DEVICES MARKET FOR CHRONIC SHORTNESS OF BREATH, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 32. PULMONARY FUNCTION TESTING DEVICES MARKET, FOR RESTRICTIVE LUNG DISEASE, BY REGION, 2021-2031 ($MILLION)
TABLE 33. PULMONARY FUNCTION TESTING DEVICES MARKET FOR RESTRICTIVE LUNG DISEASE, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 34. PULMONARY FUNCTION TESTING DEVICES MARKET, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
TABLE 35. PULMONARY FUNCTION TESTING DEVICES MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 36. GLOBAL PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 37. PULMONARY FUNCTION TESTING DEVICES MARKET, FOR HOSPITAL, BY REGION, 2021-2031 ($MILLION)
TABLE 38. PULMONARY FUNCTION TESTING DEVICES MARKET FOR HOSPITAL, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 39. PULMONARY FUNCTION TESTING DEVICES MARKET, FOR CLINICAL LABORATORIES, BY REGION, 2021-2031 ($MILLION)
TABLE 40. PULMONARY FUNCTION TESTING DEVICES MARKET FOR CLINICAL LABORATORIES, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 41. PULMONARY FUNCTION TESTING DEVICES MARKET, FOR DIAGNOSTIC LABORATORIES, BY REGION, 2021-2031 ($MILLION)
TABLE 42. PULMONARY FUNCTION TESTING DEVICES MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 43. PULMONARY FUNCTION TESTING DEVICES MARKET, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
TABLE 44. PULMONARY FUNCTION TESTING DEVICES MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 45. PULMONARY FUNCTION TESTING DEVICES MARKET, BY REGION, 2021-2031 ($MILLION)
TABLE 46. NORTH AMERICA PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 47. NORTH AMERICA PORTABLE PFT DEVICES PULMONARY FUNCTION TESTING DEVICES MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 48. NORTH AMERICA COMPLETE PFT DEVICES PULMONARY FUNCTION TESTING DEVICES MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 49. NORTH AMERICA PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 50. NORTH AMERICA PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 51. NORTH AMERICA PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 52. NORTH AMERICA PULMONARY FUNCTION TESTING DEVICES MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 53. U.S. PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 54. U.S. PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 55. U.S. PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 56. U.S. PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 57. CANADA PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 58. CANADA PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 59. CANADA PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 60. CANADA PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 61. MEXICO PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 62. MEXICO PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 63. MEXICO PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 64. MEXICO PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 65. EUROPE PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 66. EUROPE PORTABLE PFT DEVICES PULMONARY FUNCTION TESTING DEVICES MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 67. EUROPE COMPLETE PFT DEVICES PULMONARY FUNCTION TESTING DEVICES MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 68. EUROPE PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 69. EUROPE PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 70. EUROPE PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 71. EUROPE PULMONARY FUNCTION TESTING DEVICES MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 72. FRANCE PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 73. FRANCE PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 74. FRANCE PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 75. FRANCE PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 76. GERMANY PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 77. GERMANY PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 78. GERMANY PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 79. GERMANY PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 80. ITALY PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 81. ITALY PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 82. ITALY PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 83. ITALY PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 84. UK PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 85. UK PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 86. UK PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 87. UK PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 88. SPAIN PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 89. SPAIN PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 90. SPAIN PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 91. SPAIN PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 92. REST OF EUROPE PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 93. REST OF EUROPE PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 94. REST OF EUROPE PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 95. REST OF EUROPE PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 96. ASIA-PACIFIC PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 97. ASIA-PACIFIC PORTABLE PFT DEVICES PULMONARY FUNCTION TESTING DEVICES MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 98. ASIA-PACIFIC COMPLETE PFT DEVICES PULMONARY FUNCTION TESTING DEVICES MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 99. ASIA-PACIFIC PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 100. ASIA-PACIFIC PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 101. ASIA-PACIFIC PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 102. ASIA-PACIFIC PULMONARY FUNCTION TESTING DEVICES MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 103. JAPAN PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 104. JAPAN PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 105. JAPAN PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 106. JAPAN PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 107. CHINA PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 108. CHINA PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 109. CHINA PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 110. CHINA PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 111. INDIA PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 112. INDIA PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 113. INDIA PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 114. INDIA PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 115. AUSTRALIA PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 116. AUSTRALIA PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 117. AUSTRALIA PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 118. AUSTRALIA PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 119. SOUTH KOREA PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 120. SOUTH KOREA PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 121. SOUTH KOREA PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 122. SOUTH KOREA PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 123. REST OF ASIA-PACIFIC PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 124. REST OF ASIA-PACIFIC PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 125. REST OF ASIA-PACIFIC PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 126. REST OF ASIA-PACIFIC PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 127. LAMEA PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 128. LAMEA PORTABLE PFT DEVICES PULMONARY FUNCTION TESTING DEVICES MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 129. LAMEA COMPLETE PFT DEVICES PULMONARY FUNCTION TESTING DEVICES MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 130. LAMEA PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 131. LAMEA PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 132. LAMEA PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 133. LAMEA PULMONARY FUNCTION TESTING DEVICES MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 134. BRAZIL PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 135. BRAZIL PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 136. BRAZIL PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 137. BRAZIL PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 138. SAUDI ARABIA PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 139. SAUDI ARABIA PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 140. SAUDI ARABIA PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 141. SAUDI ARABIA PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 142. SOUTH AFRICA PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 143. SOUTH AFRICA PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 144. SOUTH AFRICA PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 145. SOUTH AFRICA PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 146. REST OF LAMEA PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 147. REST OF LAMEA PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 148. REST OF LAMEA PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 149. REST OF LAMEA PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 150.SCHILLER: COMPANY SNAPSHOT
TABLE 151.SCHILLER: OPERATING SEGMENTS
TABLE 152.SCHILLER: PRODUCT PORTFOLIO
TABLE 153.SCHILLER: NET SALES,
TABLE 154.SCHILLER: KEY STRATERGIES
TABLE 155.COSMED SRL: COMPANY SNAPSHOT
TABLE 156.COSMED SRL: OPERATING SEGMENTS
TABLE 157.COSMED SRL: PRODUCT PORTFOLIO
TABLE 158.COSMED SRL: NET SALES,
TABLE 159.COSMED SRL: KEY STRATERGIES
TABLE 160.NSPIRE HEALTH INC: COMPANY SNAPSHOT
TABLE 161.NSPIRE HEALTH INC: OPERATING SEGMENTS
TABLE 162.NSPIRE HEALTH INC: PRODUCT PORTFOLIO
TABLE 163.NSPIRE HEALTH INC: NET SALES,
TABLE 164.NSPIRE HEALTH INC: KEY STRATERGIES
TABLE 165.MGC DIAGNOSTICS CORPORATION: COMPANY SNAPSHOT
TABLE 166.MGC DIAGNOSTICS CORPORATION: OPERATING SEGMENTS
TABLE 167.MGC DIAGNOSTICS CORPORATION: PRODUCT PORTFOLIO
TABLE 168.MGC DIAGNOSTICS CORPORATION: NET SALES,
TABLE 169.MGC DIAGNOSTICS CORPORATION: KEY STRATERGIES
TABLE 170.NDD MEDIZINTECHNIK AG: COMPANY SNAPSHOT
TABLE 171.NDD MEDIZINTECHNIK AG: OPERATING SEGMENTS
TABLE 172.NDD MEDIZINTECHNIK AG: PRODUCT PORTFOLIO
TABLE 173.NDD MEDIZINTECHNIK AG: NET SALES,
TABLE 174.NDD MEDIZINTECHNIK AG: KEY STRATERGIES
TABLE 175.MORGAN SCIENTIFIC INC.,: COMPANY SNAPSHOT
TABLE 176.MORGAN SCIENTIFIC INC.,: OPERATING SEGMENTS
TABLE 177.MORGAN SCIENTIFIC INC.,: PRODUCT PORTFOLIO
TABLE 178.MORGAN SCIENTIFIC INC.,: NET SALES,
TABLE 179.MORGAN SCIENTIFIC INC.,: KEY STRATERGIES
TABLE 180.GANSHORN MEDIZIN ELECTRONIC: COMPANY SNAPSHOT
TABLE 181.GANSHORN MEDIZIN ELECTRONIC: OPERATING SEGMENTS
TABLE 182.GANSHORN MEDIZIN ELECTRONIC: PRODUCT PORTFOLIO
TABLE 183.GANSHORN MEDIZIN ELECTRONIC: NET SALES,
TABLE 184.GANSHORN MEDIZIN ELECTRONIC: KEY STRATERGIES
TABLE 185.MINATO HOLDINGS INC: COMPANY SNAPSHOT
TABLE 186.MINATO HOLDINGS INC: OPERATING SEGMENTS
TABLE 187.MINATO HOLDINGS INC: PRODUCT PORTFOLIO
TABLE 188.MINATO HOLDINGS INC: NET SALES,
TABLE 189.MINATO HOLDINGS INC: KEY STRATERGIES
TABLE 190.CHEST M.I., INC: COMPANY SNAPSHOT
TABLE 191.CHEST M.I., INC: OPERATING SEGMENTS
TABLE 192.CHEST M.I., INC: PRODUCT PORTFOLIO
TABLE 193.CHEST M.I., INC: NET SALES,
TABLE 194.CHEST M.I., INC: KEY STRATERGIES
TABLE 195.MEDICAL EQUIPMENT EUROPE: COMPANY SNAPSHOT
TABLE 196.MEDICAL EQUIPMENT EUROPE: OPERATING SEGMENTS
TABLE 197.MEDICAL EQUIPMENT EUROPE: PRODUCT PORTFOLIO
TABLE 198.MEDICAL EQUIPMENT EUROPE: NET SALES,
TABLE 199.MEDICAL EQUIPMENT EUROPE: KEY STRATERGIES
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
